Science & Technology
Science and Technology
Science and Technology
Wed, June 16, 2010 Simulations Plus Set to Rejoin Russell Microcap Index
LANCASTER, Calif.--([ BUSINESS WIRE ])--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, will join the Russell Microcap® Index when Russell Investments reconstitutes its family of U.S. indexes on June 25, according to a preliminary list of additions posted June 11 on [ www.russell.com ].
"Our expected addition to the Russell Microcap Index increases our visibility and credibility within the investment community"
Membership in the Russell MicrocapIndex, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.
aOur expected addition to the Russell Microcap Index increases our visibility and credibility within the investment community,a said Walt Woltosz, chairman and chief executive officer of Simulations Plus. aWe believe our inclusion in the index is directly related to the success of our aggressive sales and marketing strategy that is delivering solid fundamental improvement.a
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. An industry-leading $3.9 trillion in assets currently are benchmarked to them.
Annual reconstitution of Russell Indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization to create the Russell 3000® Index and Russell Microcap. These investment tools originated from Russell's multi-manager investment business in the early 1980s when the company saw the need for a more objective, market-driven set of benchmarks in order to evaluate outside investment managers.
Total returns data for the Russell Microcap and other Russell Indexes is available at [ http://www.russell.com/Indexes/performance/default.asp ].
About Russell
Russell Investments provides strategic advice, world-class implementation, state-of-the-art performance benchmarks and a range of institutional-quality investment products. Russell has $179 billion in assets under management as of March 31 2010, and serves individual, institutional and advisor clients in more than 40 countries. Founded in 1936, Russell is a subsidiary of The Northwestern Mutual Life Insurance Company.
About Simulations Plus, Inc.
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide, as well as a personal productivity tool for the mass market called Abbreviate!a", and an educational software series for science students in middle and high schools known as FutureLaba". Our wholly owned subsidiary, Words+, Inc., provides assistive technologies to persons with disabilities, including the communication system used by world-famous theoretical astrophysicist, Professor Stephen Hawking, of the University of Cambridge. For more information, visit our Web sites at [ www.simulations-plus.com ] and [ www.words-plus.com ].
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995a" With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. Words like abelieve,a aexpecta and aanticipatea mean that these are our best estimates as of this writing, but that there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the Company, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports as filed with the Securities and Exchange Commission.
